Prospects for reconsolidation-focused treatments of substance use and anxiety-related disorders

被引:16
|
作者
Paulus, Daniel J. [1 ,2 ]
Kamboj, Sunjeev K. [3 ]
Das, Ravi K. [3 ]
Saladin, Michael E. [1 ,4 ]
机构
[1] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Univ Houston, Dept Psychol, Houston, TX USA
[3] UCL, Res Dept Clin Educ & Hlth Psychol, Clin Psychopharamacol Unit, London, England
[4] Med Univ South Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC 29425 USA
关键词
MEMORY RECONSOLIDATION; FEAR; PROPRANOLOL; BEHAVIOR; INTERVENTION; BLOCKADE; EXPOSURE; ALCOHOL; PREVENT; RETURN;
D O I
10.1016/j.copsyc.2019.03.001
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Memories are often conceptualized as permanent entities; however, retrieval of memories via stimulus prompts can return them to an active state, which initiates a period of lability before the memories are reconsolidated into long-term storage. Importantly, during this period, memories can be disrupted/ altered. A growing body of work has focused on translating animal and experimental science into reconsolidation-based interventions for clinical disorders maintained by maladaptive memories. Interventions targeting reward-based and fear-based memories undergirding substance use and anxiety-related disorders, respectively, have shown significant potential. There are several promising pharmacological agents and behavioral approaches that have been used to therapeutically target memory reconsolidation. Here, we discuss the current state of science with special emphasis on the clinical utility of these approaches.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [31] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Alicia A. Hughes
    Jami M. Furr
    Erica D. Sood
    Andrea J. Barmish
    Philip C. Kendall
    Child Psychiatry and Human Development, 2009, 40 : 405 - 419
  • [32] Anxiety disorders and substance use disorders: Different associations by anxiety disorder
    Marmorstein, Naomi R.
    JOURNAL OF ANXIETY DISORDERS, 2012, 26 (01) : 88 - 94
  • [33] An approach to the prevention of anxiety-related disorders based on evolutionary medicine
    Grinde, B
    PREVENTIVE MEDICINE, 2005, 40 (06) : 904 - 909
  • [34] Genetic structure of anxiety-related traits: implications for neuropsychiatric disorders
    Lesch, KP
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 81 - 81
  • [35] Psychosocial treatments for women with substance use disorders
    Winhusen, TM
    Kropp, F
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2003, 30 (03) : 483 - +
  • [36] Future pharmacological treatments for substance use disorders
    Forray, Ariadna
    Sofuoglu, Mehmet
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (02) : 382 - 400
  • [37] Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders
    Hill, Kevin P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (10): : 1070 - +
  • [38] Comorbidity of substance misuse with anxiety-related and depressive disorders: a genetically informative population study of 3 million individuals in Sweden
    Virtanen, Suvi
    Kuja-Halkola, Ralf
    Mataix-Cols, David
    Jayaram-Lindstrom, Nitya
    D'Onofrio, Brian M.
    Larsson, Henrik
    Ruck, Christian
    Suvisaari, Jaana
    Lichtenstein, Paul
    Latvala, Antti
    PSYCHOLOGICAL MEDICINE, 2020, 50 (10) : 1706 - 1715
  • [39] Role of the intraparietal sulcus (IPS) in anxiety and cognition: Opportunities for intervention for anxiety-related disorders
    Brown, Lily
    White, Lauren K.
    Makhoul, Walid
    Teferi, Marta
    Sheline, Yvette I.
    Balderston, Nicholas L.
    INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY, 2023, 23 (04)
  • [40] Substance Use and Anxiety Disorders: A Scoping Review
    Goldfield, Diana
    Zhang, Molly
    George, Tony P.
    CURRENT ADDICTION REPORTS, 2024, 11 (02) : 352 - 370